{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:44:04Z","timestamp":1791495844453,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.phrs.2026.108250","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:03:01Z","timestamp":1778889781000},"page":"108250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy of Sativex\u00ae on pain, spasticity, and disability in patients with multiple sclerosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-4015","authenticated-orcid":false,"given":"Saverio","family":"Nucera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-6530","authenticated-orcid":false,"given":"Sara","family":"Ilari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Caminiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3969-1328","authenticated-orcid":false,"given":"Valeria","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4653-9098","authenticated-orcid":false,"given":"Sabina","family":"Pulone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8865-8562","authenticated-orcid":false,"given":"Chantalle","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Maiuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5350-1448","authenticated-orcid":false,"given":"Lucia Carmela","family":"Passacatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mollace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio","family":"Tasciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Muscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.phrs.2026.108250_bib1","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/nu14132711","article-title":"Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe vera and Citrus bergamia as Potential Candidates for Intestinal Health","volume":"14","author":"Maiuolo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2026.108250_bib2","unstructured":"MSIF TMSIF. Atlas of MS 3rd edition. 2020. p. 1\u201336. \u3008www.atlasofms.org\u3009."},{"issue":"14","key":"10.1016\/j.phrs.2026.108250_bib3","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler. J."},{"issue":"3","key":"10.1016\/j.phrs.2026.108250_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.phrs.2026.108250_bib5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.pain.2012.12.002","article-title":"Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis","volume":"154","author":"Foley","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2026.108250_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/B978-0-444-52001-2.00023-6","article-title":"Symptomatic treatment and management of multiple sclerosis","volume":"122","author":"Toosy","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108250_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pjnns.2014.07.009","article-title":"Symptomatology and pathogenesis of different types of pain in multiple sclerosis","volume":"48","author":"Brola","year":"2014","journal-title":"Neurol. Neurochir. Pol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108250_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejpain.2009.03.003","article-title":"Central pain in multiple sclerosis - sensory abnormalities","volume":"14","author":"Osterberg","year":"2010","journal-title":"Eur. J. Pain."},{"issue":"5","key":"10.1016\/j.phrs.2026.108250_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","article-title":"Prevalence and treatment of spasticity reported by multiple sclerosis patients","volume":"10","author":"Rizzo","year":"2004","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.phrs.2026.108250_bib10","first-page":"S49","article-title":"Spasticity Measurement","volume":"55","author":"Balci","year":"2018","journal-title":"Noro Psikiyatr Ars"},{"issue":"4","key":"10.1016\/j.phrs.2026.108250_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0269215509353254","article-title":"Rehabilitation in practice: Spasticity management","volume":"24","author":"Stevenson","year":"2010","journal-title":"Clin. Rehabil."},{"issue":"9","key":"10.1016\/j.phrs.2026.108250_bib12","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/ene.15412","article-title":"A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome","volume":"29","author":"Patti","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.phrs.2026.108250_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.714631","article-title":"Factors influencing the degree of disability in patients with multiple sclerosis","volume":"12","author":"Xue","year":"2021","journal-title":"Front Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108250_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/ijms27020873","article-title":"Chronic Pain in Multiple Sclerosis: Mechanisms, Clinical Characteristics and Treatment Strategies","volume":"27","author":"Gklinos","year":"2026","journal-title":"Int J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.phrs.2026.108250_bib15","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.3390\/jcm13195682","article-title":"Assessing Gender Differences in Neuropathic Pain Management: Findings from a Real-Life Clinical Cross-Sectional Observational Study","volume":"13","author":"Marcian\u00f2","year":"2024","journal-title":"J. Clin. Med"},{"issue":"4","key":"10.1016\/j.phrs.2026.108250_bib16","doi-asserted-by":"crossref","first-page":"s291","DOI":"10.1007\/s10072-006-0642-7","article-title":"Epidemiology and treatment of pain in multiple sclerosis subjects","volume":"27","author":"Solaro","year":"2006","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2026.108250_bib17","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.4103\/1673-5374.197125","article-title":"Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?","volume":"11","author":"Giacoppo","year":"2016","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.phrs.2026.108250_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108130","article-title":"Therapeutic use of cannabinoids in age-related pain: Current evidence and clinical perspectives","volume":"225","author":"Pulone","year":"2026","journal-title":"Pharm. Res"},{"issue":"2","key":"10.1016\/j.phrs.2026.108250_bib19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","article-title":"A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol","volume":"66","author":"Russo","year":"2006","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.phrs.2026.108250_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/13556210071252","article-title":"Neuropharmacology and therapeutic potential of cannabinoids","volume":"5","author":"Pertwee","year":"2000","journal-title":"Addict. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108250_bib21","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108250_bib22","first-page":"390","article-title":"Modifying \"Pico\" Question into \"Picos\" Model for More Robust and Reproducible Presentation of the Methodology Employed in A Scientific Study","volume":"6","author":"Saaiq","year":"2017","journal-title":"World J. Plast. Surg."},{"key":"10.1016\/j.phrs.2026.108250_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14778238.2022.2041375","article-title":"Digitalising the Systematic Literature Review process: The MySLR platform","volume":"21","author":"Ammirato","year":"2022","journal-title":"Knowl. Manag. Res. Pr."},{"issue":"11","key":"10.1016\/j.phrs.2026.108250_bib24","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/nu17111912","article-title":"Vitamin D in the Transition from Acute to Chronic Pain: A Systematic Review","volume":"17","author":"Abrego-Guandique","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2026.108250_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111595","article-title":"The association between long-term opioid use and dementia risk: A systematic review and meta-analysis","volume":"144","author":"Abrego-Guandique","year":"2026","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"20","key":"10.1016\/j.phrs.2026.108250_bib26","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3390\/nu17203232","article-title":"Does Vitamin D Supplementation Impact Fibromyalgia-Related Pain? A Systematic Review and Meta-Analysis","volume":"17","author":"Ilari","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2026.108250_bib27","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. Academic Press; Cambridge, MA, USA: 2013.","DOI":"10.4324\/9780203771587"},{"key":"10.1016\/j.phrs.2026.108250_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104711","article-title":"Nabiximols oromucosal spray in patients with multiple sclerosis-related bladder dysfunction: A prospective study","volume":"74","author":"Torri Clerici","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.phrs.2026.108250_bib29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00415-020-09739-x","article-title":"Predictors of Nabiximols (Sativex\u00ae) discontinuation over long-term follow-up: a real-life study","volume":"267","author":"Carotenuto","year":"2020","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108250_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12883-021-02246-0","article-title":"Sativex\u00ae (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience","volume":"21","author":"D'hooghe","year":"2021","journal-title":"BMC Neurol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108250_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219670","article-title":"The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray)","volume":"14","author":"Grimaldi","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2026.108250_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2947","article-title":"Non-interventional, prospective, observational study on spasticity-associated symptom control with nabiximols as add-on therapy in patients with multiple sclerosis spasticity in Austria","volume":"13","author":"Guger","year":"2023","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.phrs.2026.108250_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/nmt-2023-0040","article-title":"Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures","volume":"14","author":"Haupts","year":"2024","journal-title":"Neurodegener. Dis. Manag"},{"issue":"2023-10-1","key":"10.1016\/j.phrs.2026.108250_bib34","article-title":"Effect of nabiximols oromucosal spray (Sativex\u00ae) on symptoms associated with multiple sclerosis-related spasticity: a case series","volume":"13","author":"Garde","year":"2024","journal-title":"Drugs Context"},{"issue":"3","key":"10.1016\/j.phrs.2026.108250_bib35","first-page":"59","article-title":"Pain Modulation after Oromucosal Cannabinoid Spray (SATIVEX\u00ae) in Patients with Multiple Sclerosis: A Study with Quantitative Sensory Testing and Laser-Evoked Potentials","volume":"5","author":"Turri","year":"2018","journal-title":"Med. (Basel)"},{"issue":"8","key":"10.1016\/j.phrs.2026.108250_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180651","article-title":"SA.FE. study group. Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)","volume":"12","author":"Messina","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2026.108250_bib37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jcph.670","article-title":"Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC\/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients","volume":"56","author":"Paolicelli","year":"2016","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108250_bib38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/YIC.0000000000000126","article-title":"The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity","volume":"31","author":"Marinelli","year":"2016","journal-title":"Int Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108250_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ane.12202","article-title":"Spasticity in patients with multiple sclerosis--clinical characteristics, treatment and quality of life","volume":"129","author":"Flachenecker","year":"2014","journal-title":"Acta Neurol. Scand."},{"issue":"6","key":"10.1016\/j.phrs.2026.108250_bib40","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/pm\/pnv080","article-title":"Evaluating Sativex\u00ae in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis","volume":"17","author":"Russo","year":"2016","journal-title":"Pain. Med"},{"issue":"6","key":"10.1016\/j.phrs.2026.108250_bib41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.phrs.2026.108250_bib42","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00415-012-6739-4","article-title":"A double-blind, randomized, placebo-controlled, parallel-group study of THC\/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis","volume":"260","author":"Langford","year":"2013","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108250_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/00207454.2018.1481066","article-title":"Sativex\u00ae as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial","volume":"129","author":"Markov\u00e0","year":"2019","journal-title":"Int J. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2026.108250_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/dmcn.14165","article-title":"Cannabinoids for the treatment of spasticity","volume":"61","author":"Nielsen","year":"2019","journal-title":"Dev. Med Child Neurol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108250_bib45","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1007\/s00415-015-7878-1","article-title":"Sativex (\u00ae) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis","volume":"262","author":"Leocani","year":"2015","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108250_bib46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10072-015-2392-x","article-title":"Efficacy and safety of nabiximols (Sativex (\u00ae)) on multiple sclerosis spasticity in a real-life Italian monocentric study","volume":"37","author":"Ferr\u00e8","year":"2016","journal-title":"Neurol. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2026.108250_bib47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/PHM.0000000000000970","article-title":"Effectiveness of physiotherapy interventions on spasticity in people with multiple sclerosis: a systematic review and meta-analysis","volume":"97","author":"Etoom","year":"2018","journal-title":"Am. J. Phys. Med Rehabil."},{"issue":"2","key":"10.1016\/j.phrs.2026.108250_bib48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4274\/tjps.galenos.2018.90522","article-title":"Phytotherapy as a complementary medicine for multiple sclerosis","volume":"16","author":"Rabiei","year":"2019","journal-title":"Turk. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2026.108250_bib49","first-page":"575","article-title":"The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review","volume":"7","author":"Lewis","year":"2021","journal-title":"J. Clin. Transl. Res"},{"issue":"10","key":"10.1016\/j.phrs.2026.108250_bib50","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40263-017-0466-4","article-title":"Efficacy and Tolerability of Phytomedicines in Multiple Sclerosis Patients: A Review","volume":"31","author":"Farzaei","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2026.108250_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.985943","article-title":"Medicinal herbs and multiple sclerosis: Overview on the hard balance between new therapeutic strategy and occupational health risk","volume":"16","author":"Costantini","year":"2022","journal-title":"Front Cell Neurosci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:20:56Z","timestamp":1781454056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S1043661826001659"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108250","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Sativex\u00ae on pain, spasticity, and disability in patients with multiple sclerosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108250"}}